c-Rel Polyclonal Antibody

REL (REL proto-oncogene, NF-kB subunit) encodes a protein that belongs to the Rel homology domain/immunoglobulin-like fold, plexin, transcription factor (RHD/IPT) family. Members of this family regulate genes involved in apoptosis, inflammation, the immune response, and oncogenic processes. This proto-oncogene plays a role in the survival and proliferation of B lymphocytes. Mutation or amplification of REL is associated with B-cell lymphomas, including Hodgkin's lymphoma. Single nucleotide polymorphisms in REL are associated with susceptibility to ulcerative colitis and rheumatoid arthritis. Alternative splicing results in multiple transcript variants encoding different isoforms.

Introducing the C-REL Polyclonal Antibody, a highly effective and reliable solution for detecting and quantifying the C-REL protein in various biological samples. This antibody is produced using a unique and advanced polyclonal antibody production process, ensuring high specificity and sensitivity for the target protein.

The C-REL Polyclonal Antibody is designed to recognize and bind to the C-REL protein, a transcription factor that plays a crucial role in regulating gene expression and immune response. This antibody is suitable for a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence assays.

With its exceptional performance and versatility, the C-REL Polyclonal Antibody is an ideal tool for researchers and scientists working in the fields of immunology, oncology, and molecular biology. It is available in various sizes and formats to meet the specific needs of different research projects.

Order your C-REL Polyclonal Antibody today and experience the unparalleled quality and reliability that it offers.